United States Stool Antigen Testing Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

United States Stool Antigen Testing Market Overview

The United States Stool antigen testing market reached a value of approximately USD 674.40 Million in 2025. The market is driven by the increasing prevalence of gastrointestinal infections, growing awareness of early disease diagnosis, and rising demand for rapid, non-invasive diagnostic methods. Stool antigen testing is widely utilized for detecting bacterial, viral, and parasitic infections, particularly Helicobacter pylori. Continuous technological advancements, expanding laboratory capabilities, and increasing healthcare expenditure further support market growth across hospitals, diagnostic laboratories, and outpatient care settings.

United States Stool Antigen Testing Market Growth Analysis and Key Influencers

United States Stool Antigen Testing Market Dynamics

This section analyzes factors influencing the market, including gastrointestinal disease prevalence, diagnostic technology advancements, healthcare infrastructure, regulatory policies, laboratory expansion, reimbursement frameworks, healthcare investments, and increasing adoption of non-invasive diagnostic testing.

United States Stool Antigen Testing Market Growth Drivers

Internal Laboratory Testing Expansion Supports United States Diagnostic Market Advancement

Rising demand for faster gastrointestinal diagnosis and greater laboratory insourcing are improving access to H. pylori detection. For instance, in June 2026, Northwell Health Laboratories began performing its H. pylori stool antigen test internally rather than sending specimens to Labcorp, improving turnaround time without changing collection requirements. This development may support market growth by expanding testing capacity, strengthening workflow control, accelerating clinical decisions, and encouraging additional U.S. health systems to establish localized testing services during the forecast period.

United States Stool Antigen Testing Market Restraints

FDA Recall Intensifies Compliance Pressure Across United States Testing Providers

Stringent FDA regulatory requirements, increasing compliance obligations, and rigorous premarket clearance processes continue to challenge the United States stool antigen testing market. Manufacturers must invest significant time and resources to meet evolving regulatory standards, while non-compliant products face the risk of recalls and market withdrawal. For instance, in December 2025, the FDA classified a nationwide recall of the GetTested Peptic Ulcer Test after determining that it had been distributed without the required premarket clearance. Such regulatory actions increase compliance costs, delay product commercialization, limit market entry for smaller manufacturers, and reinforce reliance on validated laboratory-based testing, thereby restraining overall market growth during the forecast period.

United States Stool Antigen Testing Market Opportunities

Automated Immunoassay Adoption Expands United States Stool Testing Market Value

Growing hospital testing volumes and greater demand for automated immunoassays are encouraging laboratories to expand internal diagnostic capabilities. For instance, in March 2025, Corewell Health began performing H. pylori stool antigen testing on the DiaSorin LIAISON XL chemiluminescent platform at William Beaumont University Hospital. This development may create market opportunities by supporting higher throughput, faster reporting, standardized interpretation, and wider adoption of automated testing across integrated U.S. health systems and regional clinical laboratories during the forecast period.

United States Stool Antigen Testing Market Trends

Test-of-Cure Guidance Shapes United States Stool Testing Market Direction Nationwide

Rising antibiotic resistance and stronger emphasis on confirming treatment success are increasing demand for reliable noninvasive follow-up testing. For instance, in January 2025, the American College of Gastroenterology published guidance recommending a test of cure at least four weeks after therapy using a fecal antigen test, urea breath test, or biopsy-based test. These market trends may increase repeat testing, strengthen post-treatment verification, and support routine stool antigen use across U.S. gastroenterology practices during the forecast period.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

United States Stool Antigen Testing Market Share

Helicobacter pylori Detection Likely to Dominate the Market Segment by Application

The growing burden of gastrointestinal disorders, increasing awareness of early disease diagnosis, and expanding screening initiatives continue strengthening demand for stool antigen testing applications. Healthcare providers increasingly prefer accurate non-invasive testing for effective patient management. Helicobacter pylori detection held about 44% market share in the historical period and is likely to dominate the market during the forecast period, supported by rising testing volumes and widespread clinical adoption across healthcare facilities.

Leading Players in the United States Stool Antigen Testing Market

United States Stool Antigen Testing Market Segmentation

Key Questions Answered in the United States Stool Antigen Testing Market Report

• What was the United States stool antigen testing market value in 2025?
• What is the United States Stool Antigen Testing market forecast outlook for 2026-2035?
• What major factors aid the demand for the United States Stool Antigen Testing market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major United States stool antigen testing market trends?
• Which test type segment is expected to dominate the market?
• Which technology segment is expected to hold the largest market share?
• Which application is expected to account for the highest market share?
• Which end user is expected to account for the highest market share?
• Who are the key players in the United States stool antigen testing market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: Interviews with diagnostic manufacturers, laboratory managers, microbiologists, clinicians, regulatory specialists, and professionals involved in United States stool antigen testing across United States.
• Secondary Research: Sources included company announcements, FDA publications and guidance documents, CDC reports, technical documents, company annual reports, scientific journals, peer-reviewed studies, and industry publications related to stool antigen testing and gastrointestinal diagnostics.
• Validation: All quantitative estimates are triangulated using top-down and bottom-up market modeling, validated through expert feedback loops.